GlassScriptPhysician profile
Que Thu Lam Pravong
NPI 1538234349
$6,347.61
in general payments reported to CMS, 2019-2025
47 companies · $1,216 in 2025
The $1,216 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,441 · 2020: $485 · 2021: $118 · 2022: $728 · 2023: $1,261 · 2024: $1,100 · 2025: $1,216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,576.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,005.30 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $835.37 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $571.98 | 2022-2025 | |
| Glaxosmithkline, LLC. | $546.79 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Amgen INC. | $358.35 | 2019-2025 | Repatha, Prolia, Evenity |
| Lilly USA, LLC | $304.39 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $278.16 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $275.37 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $265.35 | 2019-2024 | Trintellix |
| Eisai INC. | $204.51 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $151.98 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $148.01 | 2023-2025 | |
| Exact Sciences Corporation | $137.31 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $112.89 | 2019-2025 | Capvaxive, Gardasil 9, Belsomra |
| Pfizer INC. | $109.02 | 2020-2024 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $88.97 | 2024-2025 | Korlym |
| Ibsa Pharma INC. | $76.91 | 2020-2025 | Tirosint, Licart, Flector |
| Lundbeck LLC | $65.41 | 2025 | Vyepti |
| Axsome Therapeutics, INC. | $62.92 | 2023-2025 | Auvelity |
| Biohaven Pharmaceutical Holding Company LTD. | $50.80 | 2022 | |
| Allergan, INC. | $48.67 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $46.30 | 2024-2025 | Voquezna |
| Avvisto Therapeutics, LLC | $45.56 | 2024-2025 | Cycloset |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.48 | 2019-2025 | Xifaxan |
| Astellas Pharma US INC | $41.65 | 2022-2024 | Veozah |
| Idorsia Pharmaceuticals US INC | $41.56 | 2022-2023 | Quviviq |
| Dynavax Technologies Corporation | $34.12 | 2024-2025 | Heplisav-B |
| Sanofi Pasteur INC. | $33.72 | 2019 | |
| Arbor Pharmaceuticals, INC. | $33.18 | 2019 | |
| Medtronic, INC. | $31.96 | 2022-2023 | Intellis Adaptivestim |
| Inspire Medical Systems, INC. | $26.91 | 2025 | Inspire |
| Kyowa Kirin, INC. | $24.25 | 2025 | |
| Corium, LLC | $21.69 | 2023 | Adlarity |
| Inari Medical, INC. | $20.25 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Qol Medical, LLC | $19.32 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.74 | 2019 | |
| Seqirus USA INC | $18.14 | 2024 | Fluad, Flucelvax |
| Genentech USA, INC. | $17.96 | 2019 | |
| Olympus America INC. | $17.74 | 2023 | Spin Vision Video Processor |
| Radius Health, INC. | $17.43 | 2019 | |
| Sumitomo Pharma America, INC. | $15.41 | 2025 | Gemtesa |
| Abbott Laboratories | $15.39 | 2025 | Proclaim |
| Otsuka America Pharmaceutical, INC. | $15.18 | 2025 | Rexulti |
| Neuronetics, INC. | $14.05 | 2019 | |
| Endo Pharmaceuticals INC. | $13.34 | 2022 | |
| Currax Pharmaceuticals LLC | $11.90 | 2020 | |
| Nalpropion Pharmaceuticals LLC | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Que Thu Pravong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.